Venrock Healthcare Capital Partners II, L.P. - Jun 2, 2022 Form 4 Insider Report for Tricida, Inc. (TCDA)

Role: 10%+ Owner
Signature: /s/ David L. Stepp, Authorized Signatory
Stock symbol: TCDA
Transactions as of: Jun 2, 2022
Transactions value $: $1,748,709
Form type: 4
Date filed: 6/6/2022, 05:19 PM
Previous filing: Jun 6, 2022
Next filing: Jun 9, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TCDA	Common Stock	Purchase	$542K	+61.7K	+1.09%	$8.78^*	5.74M	Jun 2, 2022	By Funds	F1, F2, F3
transaction	TCDA	Common Stock	Purchase	$351K	+37.6K	+0.66%	$9.33^*	5.77M	Jun 3, 2022	By Funds	F3, F4, F5
transaction	TCDA	Common Stock	Purchase	$856K	+91.5K	+1.58%	$9.35^*	5.87M	Jun 6, 2022	By Funds	F3, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of (i) 6,407 shares purchased by Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), (ii) 2,592 shares purchased by VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"), (iii) 13,857 shares purchased by Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), (iv), 1,383 shares purchased by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3") and (v) 37,483 shares purchased by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").
F2	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.73 to $8.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3	VHCP Management II, LLC ("VHCPM II") is the general partner of VHCP II and the manager of VHCP Co-2. VHCP Management III, LLC ("VHCPM III") is the general partner of VHCP III and the manager of VHCP Co-3. VHCP Management EG, LLC ("VHCPM EG") is the general partner of VHCP EG. Messrs. Shah and Koh are the voting members of VHCPM II, VHCPM III and VHCPM EG. Each of VHCPM II, VHCPM III, VHCPM EG, Shah and Koh expressly disclaims beneficial ownership over all shares held by VHCP II, VHCP Co-2, VHCP III, VHCP Co-3 and VHCP EG except to the extent of its or his indirect pecuniary interest therein.
F4	Consists of (i) 3,907 shares purchased by VHCP II, (ii) 1,581 shares purchased by VHCP Co-2, (iii) 8,451 shares purchased by VHCP III, (iv) 843 shares purchased by VHCP Co-3 and (v) 22,861 shares purchased by VHCP EG.
F5	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.11 to $9.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F6	Consists of (i) 9,498 shares purchased by VHCP II, (ii) 3,843 shares purchased by VHCP Co-2, (iii) 20,543 shares purchased by VHCP III, (iv) 2,050 shares purchased by VHCP Co-3 and (v) 55,572 shares purchased by VHCP EG.
F7	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.16 to $9.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.